SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Purchased by Altfest L J & Co. Inc.

Altfest L J & Co. Inc. raised its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 20.9% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 35,886 shares of the exchange traded fund’s stock after purchasing an additional 6,205 shares during the period. Altfest L J & Co. Inc.’s holdings in SPDR S&P Biotech ETF were worth $3,204,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Resources Management Corp CT ADV boosted its position in shares of SPDR S&P Biotech ETF by 1,715.8% in the second quarter. Resources Management Corp CT ADV now owns 345 shares of the exchange traded fund’s stock worth $29,000 after acquiring an additional 326 shares during the last quarter. Tyler Stone Wealth Management acquired a new stake in shares of SPDR S&P Biotech ETF in the second quarter worth approximately $33,000. EPG Wealth Management LLC boosted its position in shares of SPDR S&P Biotech ETF by 152.7% in the third quarter. EPG Wealth Management LLC now owns 460 shares of the exchange traded fund’s stock worth $34,000 after acquiring an additional 278 shares during the last quarter. Compass Wealth Management LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter worth approximately $34,000. Finally, Fortis Capital Advisors LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter worth approximately $38,000.

SPDR S&P Biotech ETF Price Performance

XBI stock traded up $2.06 during midday trading on Wednesday, reaching $94.75. 6,144,737 shares of the company’s stock traded hands, compared to its average volume of 11,686,499. The company has a market capitalization of $7.27 billion, a P/E ratio of 11.47 and a beta of 0.97. The business has a 50-day moving average price of $93.14 and a two-hundred day moving average price of $82.48. SPDR S&P Biotech ETF has a fifty-two week low of $63.80 and a fifty-two week high of $103.52.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.